Powering Global Access: Building a Reliable, Efficient Pharmaceutical Supply Chain
FiercePharma
While 47% of the world population has not received a single dose yet, the COVID-19 vaccine rollout still represents a monumental effort.
Fierce Pharma spoke with AmerisourceBergen about building a reliable, efficient pharmaceutical supply chain and why the lessons learned from the distribution efforts will result in lasting changes and new considerations that will strengthen the industry.